tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of John Newman, 137 are a BUY (90.13%), 15 are a HOLD (9.87%).
Analyst John Newman, currently employed at CANACCORD, carries an average stock price target met ratio of 41.27% that have a potential upside of 23.87% achieved within 120 days.
John Newman’s has documented 285 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on ATRA, Atara Biotherapeutics at 13-Jan-2026.
Analyst best performing recommendations are on APTO (APTOSE BIOSCIENCES).
The best stock recommendation documented was for ACLX (ARCELLX) at 4/19/2023. The price target of $40 was fulfilled within 5 days with a profit of $4.74 (13.44%) receiving and performance score of 26.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2025
$65
$37.04 (132.47%)
$48
3 days ago
(12-Feb-2026)
0/4 (0%)
$37.29 (134.57%)
Hold Since 01-Dec-2022
$25
$-2.96 (-10.59%)
$20
1 months 9 days ago
(06-Jan-2026)
5/7 (71.43%)
$-2.47 (-8.99%)
181
Buy Since 20-Nov-2025
$40
$12.04 (43.06%)
$34
1 months 20 days ago
(26-Dec-2025)
11/16 (68.75%)
$11.98 (42.76%)
205
Buy Since 24-Nov-2025
$38
$10.04 (35.91%)
$32
1 months 22 days ago
(24-Dec-2025)
6/9 (66.67%)
$8.83 (30.27%)
71
Buy Since 03-Dec-2021
$34
$6.04 (21.60%)
$32
1 months 22 days ago
(24-Dec-2025)
6/12 (50%)
$4.83 (16.56%)
477
Which stock is John Newman is most bullish on?
Which stock is John Newman is most reserved on?
What Year was the first public recommendation made by John Newman?
